Loading...
•
Sep 30, 2021
Semler Scientific Q3 2021 Earnings Report
Semler Scientific's Q3 2021 financial performance reflected a revenue increase compared to the same period last year, but net income decreased.
Key Takeaways
Semler Scientific reported a 30% increase in revenue for Q3 2021 compared to Q3 2020, reaching $14.0 million. However, net income decreased by 15% to $4.2 million, and diluted EPS decreased to $0.51.
Revenue increased by 30% compared to the same quarter last year.
Net income decreased by 15% compared to the same quarter last year.
Cost of revenues increased to 10% of revenues, compared to 8% in the prior year.
Cash and cash equivalents increased to $35.9 million.
Forward Guidance
Semler Scientific expects continued profitability and generation of cash from operating activities for the remainder of 2021 and in 2022. The company intends to grow annual revenues at a faster rate than annual expenses and to remain profitable.
Positive Outlook
- Continued profitability expected
- Generation of cash from operating activities expected
- Intent to grow annual revenues at a faster rate than annual expenses
- Aim to remain profitable
- Focus on expanding product offerings
Challenges Ahead
- Uncertainty created by COVID-19
- Risk of insurance plans discontinuing licenses
- Risk of customers discontinuing licenses
- Potential inability to expand product offerings successfully
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...